New ALS Treatment, AMX0035, Lacks Evidence of Benefit, FDA Panel Finds
The main goal was to slow down the fall by a 48-point ALS scale assessment of 12 physical abilities, including walking, speaking, swallowing, dressing, handwriting, and breathing. “This is the first time we’ve seen improvements in...